Works matching IS 10781552 AND DT 2018 AND VI 24

Results: 101

A case of aseptic meningitis in a cetuximab-experienced patient with metastatic colon cancer.

Published in:

Journal of Oncology Pharmacy Practice, 2018, v. 24, n. 8, p. 632, doi. 10.1177/1078155217739685

By:

Rohrer, Chelsea L.;
Grullon, Zunilda;
George, Sarah K.;
Castillo, Raul;
Karasiewicz, Kelli

Publication type:

Article

Sirolimus and mirabegron interaction in a hematopoietic cell transplant patient.

Published in:

Journal of Oncology Pharmacy Practice, 2018, v. 24, n. 8, p. 627, doi. 10.1177/1078155217726161

By:

Engle, Jeff A.;
Fair, Christina

Publication type:

Article

Severe sunitinib-induced myelosuppression in a patient with a CYP 3A4 polymorphism.

Published in:

Journal of Oncology Pharmacy Practice, 2018, v. 24, n. 8, p. 623, doi. 10.1177/1078155217724863

By:

Patel, Nirav D.;
Chakrabory, Kanishka;
Krishnan, Koyamangalath;
Messmer, Garrett;
Bossaer, John B.

Publication type:

Article

Start using a checklist, PRONTO: Recommendation for a standard review process for chemotherapy orders.

Published in:

Journal of Oncology Pharmacy Practice, 2018, v. 24, n. 8, p. 609, doi. 10.1177/1078155217722594

By:

Crandell, Brian C.;
Bates, Jill S.;
Grgic, Tatjana

Publication type:

Article

Making moves: Transitioning R-EPOCH to the ambulatory setting.

Published in:

Journal of Oncology Pharmacy Practice, 2018, v. 24, n. 8, p. 617, doi. 10.1177/1078155217722408

By:

Martin, Allison L.;
Frank, Joel P.;
Waggoner, Mindy L.

Publication type:

Article

Retrospective analysis of goal drug level attainment of posaconazole for invasive fungal infection prophylaxis in patients with acute myeloid leukemia pre- and post-switch to tablet formulation.

Published in:

Journal of Oncology Pharmacy Practice, 2018, v. 24, n. 8, p. 599, doi. 10.1177/1078155217722405

By:

Liebenstein, Tyler K.;
Widmer, Kristin M.;
Fallon, Michael J.

Publication type:

Article

Dapsone and azole interactions: A clinical perspective.

Published in:

Journal of Oncology Pharmacy Practice, 2018, v. 24, n. 8, p. 637, doi. 10.1177/1078155217722048

By:

Corallo, Carmela;
Coutsouvelis, John;
Avery, Sharon;
Morgan, Susan;
Morrissey, Orla

Publication type:

Article

A deliberative framework to identify the need for real-life evidence building of new cancer drugs after interim funding decision.

Published in:

Journal of Oncology Pharmacy Practice, 2018, v. 24, n. 8, p. 584, doi. 10.1177/1078155217722047

By:

Leung, Leanne;
de Lemos, Mário L.;
Kovacic, Laurel

Publication type:

Article

Evaluation of pegfilgrastim use at an academic medical center.

Published in:

Journal of Oncology Pharmacy Practice, 2018, v. 24, n. 8, p. 604, doi. 10.1177/1078155217722046

By:

Tang, Kathy;
Duffy, Alison;
Gilmore, Steven

Publication type:

Article

An evaluation of chemotherapy drug preparation process in hospitals in Turkey – A pilot study.

Published in:

Journal of Oncology Pharmacy Practice, 2018, v. 24, n. 8, p. 563, doi. 10.1177/1078155217720007

By:

Bayraktar-Ekincioglu, Aygin;
Demirkan, Kutay;
Korubük, Gamze

Publication type:

Article

Assessment of the potential impact of dose rounding parenteral chemotherapy agents on cost savings and drug waste minimization.

Published in:

Journal of Oncology Pharmacy Practice, 2018, v. 24, n. 7, p. 507, doi. 10.1177/1078155217722205

By:

Chillari, Kelly A.;
Southward, Jessica;
Harrigan, Natasha

Publication type:

Article

Loperamide and cardiac events: Is high-dose use still safe for chemotherapy-induced diarrhea?

Published in:

Journal of Oncology Pharmacy Practice, 2018, v. 24, n. 8, p. 634, doi. 10.1177/1078155217718384

By:

de Lemos, Mário L.;
Kletas, Victoria;
Guenter, Jolene

Publication type:

Article

Abstracts.

Published in:: Journal of Oncology Pharmacy Practice, 2018, v. 24, p. 1, doi. 10.1177/1078155218796724
Publication type:: Article

Irinotecan-induced muscle twitching from a possible drug interaction: A case report.

Published in:

Journal of Oncology Pharmacy Practice, 2018, v. 24, n. 7, p. 555, doi. 10.1177/1078155217723696

By:

Bettinger, J.;
Philip, J.;
Peters, S. S.;
Karhan, B.;
Wrzesinski, S. H.

Publication type:

Article

Two cases of combination therapy with cetuximab, paclitaxel, and cisplatin for advanced head and neck cancer.

Published in:

Journal of Oncology Pharmacy Practice, 2018, v. 24, n. 7, p. 553, doi. 10.1177/1078155217722406

By:

Hoch, Matthew A.;
Cousins, Kati;
Nartey, Ruth;
Riley, Keith;
Hartranft, Megan

Publication type:

Article

Real-world chart review study of adverse events management in patients taking tyrosine kinase inhibitors to treat metastatic renal cell carcinoma.

Published in:

Journal of Oncology Pharmacy Practice, 2018, v. 24, n. 8, p. 574, doi. 10.1177/1078155217719583

By:

Srinivas, Sandy;
Stein, Dara;
Tao, Sunning;
Teltsch, Dana Y.;
Cisar, Laura;
Ramaswamy, Krishnan

Publication type:

Article

The clinical significance of QT prolongation associated with tamoxifen: A review of the literature.

Published in:

Journal of Oncology Pharmacy Practice, 2018, v. 24, n. 7, p. 525, doi. 10.1177/1078155217720006

By:

Fung, Katherine;
Imeson, Julia;
Cusano, Frances

Publication type:

Article

Gemcitabine associated pseudocellulitis: A missed diagnosis.

Published in:

Journal of Oncology Pharmacy Practice, 2018, v. 24, n. 7, p. 550, doi. 10.1177/1078155217719584

By:

Gill, Dalvir;
Kelly, Matthew;
Martinez, Fidel;
Syed, Wajihuddin;
Wright, Jonathan;
Schrader, Josh

Publication type:

Article

Ibrutinib-associated tumor lysis syndrome in chronic lymphocytic leukemia/small lymphocytic lymphoma and mantle cell lymphoma: A case series and review of the literature.

Published in:

Journal of Oncology Pharmacy Practice, 2018, v. 24, n. 7, p. 544, doi. 10.1177/1078155217718617

By:

Titus-Rains, Krystal S.;
Brown, Jamie N.;
Hammond, Julia M.

Publication type:

Article

Interstitial lung disease following FOLFOX + FOLFIRI and bevacizumab therapy associated with leucovorin: A case report.

Published in:

Journal of Oncology Pharmacy Practice, 2018, v. 24, n. 7, p. 540, doi. 10.1177/1078155217718616

By:

Mitsuboshi, Satoru;
Kozakai, Hiromi;
Yamada, Hitoshi;
Nagai, Kazuhiko;
Furukawa, Tomoyasu;
Aizawa, Kikuo

Publication type:

Article

Retrospective comparison of low molecular weight heparin vs. warfarin vs. oral Xa inhibitors for the prevention of recurrent venous thromboembolism in oncology patients: The Re-CLOT study.

Published in:

Journal of Oncology Pharmacy Practice, 2018, v. 24, n. 7, p. 494, doi. 10.1177/1078155217718382

By:

Alzghari, Saeed K.;
Baty, Kimberly A.;
Herrington, Jon D.;
Seago, Susan E.;
Garza, Jessica E.;
Hashimie, Yasmeen F.;
Evans, Martha F.;
Shaver, Courtney

Publication type:

Article

Venetoclax: A novel B-cell lymphoma-2 inhibitor for chronic lymphocytic leukemia and other hematologic malignancies.

Published in:

Journal of Oncology Pharmacy Practice, 2018, v. 24, n. 7, p. 517, doi. 10.1177/1078155217718383

By:

Olin, Jacqueline L.;
Griffiths, Carrie L.;
Smith, Morgan B.

Publication type:

Article

Retraction notice.

Published in:: Journal of Oncology Pharmacy Practice, 2018, v. 24, n. 6, p. NP1, doi. 10.1177/1078155218790179
Publication type:: Article

Utilization of capecitabine plus oxaliplatin and 5-fluorouracil/folinic acid plus oxaliplatin in the adjuvant treatment of stage IIB and stage III colon cancer: A multi-centre, retrospective, chart review study.

Published in:

Journal of Oncology Pharmacy Practice, 2018, v. 24, n. 7, p. 501, doi. 10.1177/1078155217718381

By:

Sha, Aaron;
Abadi, Shirin;
Gill, Sharlene

Publication type:

Article

Prevalence study on potential drug–drug interaction in cancer patients in Piacenza hospital’s Onco-Haematology department.

Published in:

Journal of Oncology Pharmacy Practice, 2018, v. 24, n. 7, p. 490, doi. 10.1177/1078155217717324

By:

Vecchia, Stefano;
Confalonieri, Corrado;
Damonti, Enrico;
Riva, Alessandra;
Sartori, Alessia;
Orlandi, Elena;
Cavanna, Luigi

Publication type:

Article

Ethanol-induced symptoms in patients receiving gemcitabine diluted from a concentrate for solution for infusion containing ethanol.

Published in:

Journal of Oncology Pharmacy Practice, 2018, v. 24, n. 7, p. 511, doi. 10.1177/1078155217715790

By:

Diez-Fernández, Raúl;
Vázquez-Sánchez, Rocío;
López-Esteban, Laura;
Molina-García, Teresa;
Enrech-Frances, Santos;
Sánchez-Peña, Ana María;
Díaz-Paniagua, Laura;
Soria-Tristán, Miguel;
Martín Martínez, José Miguel

Publication type:

Article

Docetaxel-induced cardiac-respiratory arrest in a patient with chronic atrial fibrillation.

Published in:

Journal of Oncology Pharmacy Practice, 2018, v. 24, n. 7, p. 531, doi. 10.1177/1078155217714860

By:

Huq, Mostaqul;
Balvanz, Tracie M.;
Mambourg, Scott

Publication type:

Article

Carry-over of antineoplastic drug contamination in Dutch hospital pharmacies.

Published in:

Journal of Oncology Pharmacy Practice, 2018, v. 24, n. 7, p. 483, doi. 10.1177/1078155217704990

By:

Crul, M.;
Simons-Sanders, K.

Publication type:

Article

Drug–drug interaction related to the use of pipamperon and ondansetron in a child treated for leukemia.

Published in:

Journal of Oncology Pharmacy Practice, 2018, v. 24, n. 7, p. 537, doi. 10.1177/1078155217717325

By:

Bauters, Tiene;
Buts, Sarah;
Bordon, Victoria;
Laureys, Geneviève

Publication type:

Article

A response to the letter to the editor on “Management of hepatitis B reactivation in lymphoma patients on rituximab with past hepatitis B exposure: An observational study”.

Published in:

Journal of Oncology Pharmacy Practice, 2018, v. 24, n. 6, p. 478, doi. 10.1177/1078155218782614

By:

Yeo, Denise;
Hossain, Ihtimam;
Lim, Soon Thye;
Farid, Mohamad;
Tao, Miriam;
Quek, Richard;
Tang, Tiffany;
Chan, Alexandre

Publication type:

Article

Does resolved HBV or anti-HBc-only carry the same risk of HBV reactivation?

Published in:

Journal of Oncology Pharmacy Practice, 2018, v. 24, n. 6, p. 477, doi. 10.1177/1078155218782593

By:

Ozaras, Resat;
Uraz, Suleyman;
Demirel, Aslihan;
Mete, Bilgul;
Tabak, Fehmi

Publication type:

Article

RETRACTED: Cost-utility analysis of trastuzumab combined with Docetaxel for patients with HER-2 positive metastatic breast cancer – real world claim data.

Published in:

2018

By:

Leung, Henry W. C.;
Chan, Agnes L. F.;
Wang, Shyh-Yau

Publication type:

Correction Notice

Pharmaceutical assistance programs for cancer patients in the era of orally administered chemotherapeutics.

Published in:

Journal of Oncology Pharmacy Practice, 2018, v. 24, n. 6, p. 424, doi. 10.1177/1078155217719585

By:

Mitchell, Aaron;
Muluneh, Benyam;
Patel, Rachana;
Basch, Ethan

Publication type:

Article

Do checkpoint inhibitors rely on gut microbiota to fight cancer?

Published in:

Journal of Oncology Pharmacy Practice, 2018, v. 24, n. 6, p. 468, doi. 10.1177/1078155217715903

By:

Firwana, Belal;
Avaritt, Nathan;
Shields, Bradley;
Ravilla, Rahul;
Makhoul, Issam;
Hutchins, Laura;
Tackett, Alan J.;
Mahmoud, Fade

Publication type:

Article

Meta-analysis and indirect treatment comparison of lipegfilgrastim with pegfilgrastim and filgrastim for the reduction of chemotherapy-induced neutropenia-related events.

Published in:

Journal of Oncology Pharmacy Practice, 2018, v. 24, n. 6, p. 412, doi. 10.1177/1078155217714859

By:

Bond, T. Christopher;
Szabo, Erika;
Gabriel, Susan;
Klastersky, Jean;
Tomey, Omar;
Mueller, Udo;
Schwartzberg, Lee;
Tang, Boxiong

Publication type:

Article

A review of CD19-targeted immunotherapies for relapsed or refractory acute lymphoblastic leukemia.

Published in:

Journal of Oncology Pharmacy Practice, 2018, v. 24, n. 6, p. 453, doi. 10.1177/1078155217713363

By:

DasGupta, Ryan K.;
Marini, Bernard L.;
Rudoni, Joslyn;
Perissinotti, Anthony J.

Publication type:

Article

BCR-ABL1 tyrosine kinase inhibitors for the treatment of chronic myeloid leukemia.

Published in:

Journal of Oncology Pharmacy Practice, 2018, v. 24, n. 6, p. 433, doi. 10.1177/1078155217710553

By:

Cuellar, Sandra;
Vozniak, Michael;
Rhodes, Jill;
Forcello, Nicholas;
Olszta, Daniel

Publication type:

Article

Cost-effectiveness and safety of ramucirumab plus paclitaxel chemotherapy in the treatment of advanced and recurrent gastric cancer.

Published in:

Journal of Oncology Pharmacy Practice, 2018, v. 24, n. 6, p. 403, doi. 10.1177/1078155217707335

By:

Kimura, Michio;
Usami, Eiseki;
Teramachi, Hitomi;
Yoshimura, Tomoaki

Publication type:

Article

How can we ensure value for money from expenditure on injectable cancer drugs?

Published in:

Journal of Oncology Pharmacy Practice, 2018, v. 24, n. 6, p. 473, doi. 10.1177/1078155217706195

By:

Gilbar, Peter J.;
Chambers, Carole R.

Publication type:

Article

Research - Non-Clinical.

Published in:: Journal of Oncology Pharmacy Practice, 2018, v. 24, p. 21
Publication type:: Article

Research - Clinical.

Published in:: Journal of Oncology Pharmacy Practice, 2018, v. 24, p. 11
Publication type:: Article

Pharmacy Practice.

Published in:: Journal of Oncology Pharmacy Practice, 2018, v. 24, p. 6
Publication type:: Article

Administration.

Published in:: Journal of Oncology Pharmacy Practice, 2018, v. 24, p. 1, doi. 10.1177/1078155218764286
Publication type:: Article

Why overall survival and not progression free survival improves in era of program death inhibitors.

Published in:

Journal of Oncology Pharmacy Practice, 2018, v. 24, n. 5, p. 398, doi. 10.1177/1078155217712402

By:

Dada, Reyad

Publication type:

Article

Osimertinib: A third-generation tyrosine kinase inhibitor for treatment of epidermal growth factor receptor-mutated non-small cell lung cancer with the acquired Thr790Met mutation.

Published in:

Journal of Oncology Pharmacy Practice, 2018, v. 24, n. 5, p. 379, doi. 10.1177/1078155217712401

By:

Bollinger, Meredith K.;
Agnew, Amanda S.;
Mascara, Gerard P.

Publication type:

Article

Interdisciplinary implementation of tacrolimus intravenous standard concentration in hematopoietic stem cell transplantation recipients.

Published in:

Journal of Oncology Pharmacy Practice, 2018, v. 24, n. 5, p. 365, doi. 10.1177/1078155217710552

By:

Shank, Brandon R.;
Deaver, Melissa;
Baker, Angela;
Myers, Alan L.;
Zhang, Yan-Ping;
Anderegg, Brent;
Bassett, Roland;
Westmoreland, Michael

Publication type:

Article

Levocarnitine and vitamin B complex for the treatment of pegaspargase-induced hepatotoxicity: A case report and review of the literature.

Published in:

Journal of Oncology Pharmacy Practice, 2018, v. 24, n. 5, p. 393, doi. 10.1177/1078155217710714

By:

Blackman, Alison;
Boutin, Alyssa;
Shimanovsky, Alexei;
Baker, William J.;
Forcello, Nicholas

Publication type:

Article

The impact of pharmacist telephone calls after discharge on satisfaction of oncology patients: A randomized controlled study.

Published in:

Journal of Oncology Pharmacy Practice, 2018, v. 24, n. 5, p. 359, doi. 10.1177/1078155217709616

By:

Salmany, Sewar S.;
Ratrout, Lujeen;
Amireh, Abdallah;
Agha, Randa;
Nassar, Noor;
Mahmoud, Nour;
Rimawi, Dalia;
Nazer, Lama

Publication type:

Article

Impact of a specialty pharmacy case management service on adherence in patients receiving oral antineoplastic agents.

Published in:

Journal of Oncology Pharmacy Practice, 2018, v. 24, n. 5, p. 371, doi. 10.1177/1078155217708022

By:

Middendorff, Grant;
Elsey, Rachel;
Lounsbery, Brian;
Chadwell, Roxanne

Publication type:

Article

Prediction of cardiovascular risk in cancer patients of South India using WHO/ISH risk prediction charts and Framingham score – A prospective study.

Published in:

Journal of Oncology Pharmacy Practice, 2018, v. 24, n. 5, p. 354, doi. 10.1177/1078155217707334

By:

Rajanandh, M. G.;
Suresh, S.;
Manobala, K.;
Nandhakumar, R.;
Jaswanthi, G.;
Neha, S.

Publication type:

Article